BreezeMeds is a telehealth weight loss platform that connects patients with licensed healthcare providers for GLP-1 medications. The service is 100% online with no in-person visits required. You complete a health assessment, a licensed provider reviews your information and determines eligibility, and if approved, medication ships directly to your home. The medical team operates through Lion MD, led by Dr. Ana Lisa Carr MD and Dr. Kelly Tenbrink MD.
BreezeMeds offers compounded GLP-1 medications including semaglutide injections (weekly), oral semaglutide (daily dissolving tablets), and oral tirzepatide (daily dissolving tablets). They also offer NAD+ injections and sermorelin for metabolic support. These are compounded medications prepared by partner pharmacies, not FDA-approved brand-name drugs like Wegovy, Ozempic, or Zepbound. Compounded drugs have not been evaluated by the FDA for safety, effectiveness, or quality.
Semaglutide weekly injections start at $199/month, oral semaglutide at $299/month, and oral tirzepatide at $399/month. NAD+ injections start at $169 and sermorelin at $100/month. Pricing includes the medical consultation, prescription, medication, and free shipping. No subscription is required, and payments are FSA/HSA eligible. Insurance is not accepted.
BreezeMeds partners with four compounding pharmacies: Belmar Pharmacy (Golden, Colorado), Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx. Belmar Pharmacy is a well-established compounding facility with over 30 years of experience and ISO-certified cleanrooms. Strive Pharmacy follows USP standards for sterile compounding. These pharmacies prepare customized formulations based on prescriptions from BreezeMeds providers.
